Results 201 to 210 of about 4,446,627 (280)

Comb‐Driven Coherent Optical Transmitter for Scalable DWDM Interconnects

open access: yesLaser &Photonics Reviews, Volume 20, Issue 19, 7 October 2026.
A comb‐driven coherent optical transmitter on a Si/SiN platform enables scalable DWDM interconnects by integrating ultra‐compact microring‐assisted modulators and interleavers. High‐baud coherent signaling achieves 400 Gb/s per wavelength and >$>$1 Tb/s multi‐channel transmission, with projected >$>$10 Tb/s per fiber, offering a path toward energy ...
Alireza Geravand   +11 more
wiley   +1 more source

Integrating fixed and mobile coherent optical access networks for unified broadband services. [PDF]

open access: yesCommun Eng
Wu Q   +10 more
europepmc   +1 more source

Femtosecond‐Laser‐Inscribed Cladding Fiber Bragg Gratings: Architectures, Design Trade‐Offs and Future Sensing Opportunities

open access: yesLaser &Photonics Reviews, Volume 20, Issue 19, 7 October 2026.
Femtosecond‐laser inscription enables precise positioning of fiber Bragg gratings within the cladding, introducing new spatial and modal design freedoms. Auxiliary‐waveguide, near‐core evanescent‐field, and direct cladding‐mode‐excitation architectures provide complementary pathways toward multiparameter, vector, distributed, and environmentally ...
Koustav Dey   +3 more
wiley   +1 more source

Optical genome mapping enhanced by refined variant interpretation in pediatric acute lymphoblastic leukemia

open access: yesThe Journal of Pathology, Volume 270, Issue 2, Page 241-254, October 2026.
Abstract Reliable detection of structural variants (SVs) and copy number variations (CNVs) is crucial in the contemporary diagnostics of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). However, limitations of commonly used conventional and molecular cytogenetic methods may hinder the accurate genetic characterization of patients.
Anna Bekő   +21 more
wiley   +1 more source

Tissue Factor‐High Ovarian Clear Cell Carcinoma Shows Immune‐Cold Features and Preclinical Activity of Tisotumab Vedotin

open access: yesCancer Science, Volume 117, Issue 10, Page 2838-2851, October 2026.
F3/TF‐high ovarian clear cell carcinoma exhibits an immune‐cold phenotype characterized by reduced immune‐cell fractions and attenuated cancer‐cell interferon programs, with frequent B7‐H4 co‐expression. Patient‐derived models show preclinical sensitivity to the TF‐directed antibody–drug conjugate tisotumab vedotin.
Yutaro Mori   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy